Operating income decreased 48.4%
Operating income changed -48.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -48.4% from the comparable as-filed period.
Operating margin changed +30724 basis points from the comparable as-filed period.
Revenue changed +63.3% from the comparable as-filed period.
Research & development changed +43.0% from the comparable as-filed period.
Total assets changed +583.4% from the comparable as-filed period.
Current assets changed +709.2% from the comparable as-filed period.
Inventory changed -98.2% from the comparable as-filed period.
Capex / revenue changed -2267 basis points from the comparable as-filed period.
Current liabilities changed +37.6% from the comparable as-filed period.
Selling, general & administrative changed +67.6% from the comparable as-filed period.
Stock-based compensation changed +150.9% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.